Reproductive and menopausal factors and risk of systemic lupus erythematosus in women

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1251-1262

  Costenbader, Karen H ^a   Feskanich, Diane ^a   Stampfer, Meir J ^a   Karlson, Elizabeth W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; MENOPAUSE; MENSTRUAL IRREGULARITY; MULTIVARIATE ANALYSIS; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENARCHE; MENOPAUSE, PREMATURE; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCTION; RISK FACTORS; SEX FACTORS;

EID: 34247193197     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22510     Document Type: Article

References (58)

1. Grimes DA, LeBolt SA, Grimes KR, Wingo PA. Systemic lupus erythematosus and reproductive function: a case-control study. Am J Obstet Gynecol 1985;153:179-86.
2. Minami Y, Sasaki T, Komatsu S, Nishikori M, Fukao A, Yoshinaga K, et al. Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 1993;169:245-52.
3. Nagata C, Fujita S, Iwata H, Kurosawa Y, Kobayashi K, Kobayashi M, et al. Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 1995;34:333-7.
4. Cooper GS, Dooley MA, Treadwell EL, St.Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 2002;46:1830-9.
5. Petri M, Thompson E, Abusuwwa R, Huang J, Garrett E. BALES: The Baltimore Lupus Environmental Study [abstract]. Arthritis Rheum 2001;44 Suppl 9:S331.
6. Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus: a prospective study. Arch Intern Med 1991;151:269-73.
7. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-7.
8. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004;13:688-9.
9. Hochberg MC, Kaslow RA. Risk factors for the development of systemic lupus erythematosus [abstract]. Clin Res 1983;31:732A.
10. Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
11. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1997;40:804-8.
12. Hunter DJ, Manson JE, Colditz GA, Chasan-Taber L, Troy L, Stampfer MJ, et al. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception 1997;56:373-8.
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
15. Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz JN, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995;5:297-302.
16. Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B, Hennekens CH, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-25.
17. Costenbader KH, Kim DJ, Peerzada J, Lockman S, Nobles-Knight D, Petri M, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004;50:849-57.
18. Adair LS. Size at birth predicts age at menarche. Pediatrics 2001;107:e59-66.
19. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter DJ, et al. Birthweight as a risk factor for breast cancer. Lancet 1996;348:1542-6.
20. Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol 1993;138:56-64.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
22. SAS. 9th ed. Cary (NC): SAS Institute; 1990.
23. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
24. Loesch DZ, Huggins R, Rogucka E, Hoang NH, Hopper JL. Genetic correlates of menarcheal age: a multivariate twin study. Ann Hum Biol 1995;22:470-90.
25. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr 2005;147:753-60.
26. Leenstra T, Petersen LT, Kariuki SK, Oloo AJ, Kager PA, ter Kuile FO. Prevalence and severity of malnutrition and age at menarche: cross-sectional studies in adolescent schoolgirls in western Kenya. Eur J Clin Nutr 2005;59:41-8.
27. Ersoy B, Balkan C, Gunay T, Egemen A. The factors affecting the relation between the menarcheal age of mother and daughter. Child Care Health Dev 2005;31:303-8.
28. Torstveit MK, Sundgot-Borgen J. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls. Br J Sports Med 2005;39:141-7.
29. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willett WC, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol 2004;104(5 Pt 1):965-74.
30. Garland M, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Spiegelman D, et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998;147:636-43.
31. Colditz GA. Epidemiology of breast cancer: findings from the Nurses' Health Study. Cancer 1993;71(4 Suppl):1480-9.
32. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-26.
33. Dos Santos Silva I, de Stavola BL, Hardy RJ, Kuh DJ, McCormack VA, Wadsworth ME. Is the association of birth weight with premenopausal breast cancer risk mediated through childhood growth? Br J Cancer 2004;91:519-24.
34. De Stavola BL, dos Santos Silva I, McCormack V, Hardy RJ, Kuh DJ, Wadsworth ME. Childhood growth and breast cancer. Am J Epidemiol 2004;159:671-82.
35. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002;109:1625-33.
36. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest 2003;111:275-83.
37. Lahita RG. Sex steroids and the rheumatic diseases. Arthritis Rheum 1985;28:121-6.
38. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16 α-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.
39. Vera-Lastra O, Jara LJ, Espinoza LR. Prolactin and autoimmunity. Autoimmun Rev 2002;1:360-4.
40. Chapel TA, Burns RE. Oral contraceptives and exacerbation of lupus erythematosus. Am J Obstet Gynecol 1971;110:366-9.
41. Lahita RG. The importance of estrogens in systemic lupus erythematosus. Clin Immunol Immunopathol 1992;63:17-8.
42. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus [review]. Arthritis Rheum 1997;40:797-803.
43. Petri MA, Lahita RG, van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al, for the GL701 Lupus Study Group. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002;46:1820-9.
44. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:2924-7.
45. Grimaldi CM, Hill L, Xu X, Peeva E, Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol Immunol 2005;42:811-20.
46. McMurray RW, May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis [review]. Arthritis Rheum 2003;48:2100-10.
47. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al, for the OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
48. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005;353:2539-49.
49. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142(12 Pt 1):953-62.
50. Johansson M, Arlestig L, Moller B, Smedby T, Rantapaa-Dahlqvist S. Oestrogen receptor α gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 2005;64:1611-7.
51. Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B, Cha HS, et al. Association of the oestrogen receptor α gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 2004;63:1244-9.
52. Kassi E, Vlachoyiannopoulos PG, Kominakis A, Kiaris H, Moutsopoulos HM, Moutsatsou P. Estrogen receptor α gene polymorphism and systemic lupus erythematosus: a possible risk? Lupus 2005;14:391-8.
53. Kobayashi N, Fujino T, Shirogane T, Furuta I, Kobamatsu Y, Yaegashi M, et al. Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 2002;41:193-201.
54. Suuriniemi M, Mahonen A, Kovanen V, Alen M, Lyytikainen A, Wang Q, et al. Association between exercise and pubertal BMD is modulated by estrogen receptor α genotype. J Bone Miner Res 2004;19:1758-65.
55. Stavrou I, Zois C, Ioannidis JP, Tsatsoulis A. Association of polymorphisms of the oestrogen receptor α gene with the age of menarche. Hum Reprod 2002;17:1101-5.
56. Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schuit SC, Hofman A, et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999;84:3146-50.
57. Alarcon GS, McGwin G Jr, Sanchez ML, Bastian HM, Fessler BJ, Friedman AW, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum 2004;51:73-7.
58. Alarcon GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman J, et al, for the LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006;65:1168-74.